Meeting
2019 Genitourinary Cancers Symposium
Value of serum neuroendocrine markers in evaluation of neuroendocrine prostate cancer: A validation study using metastatic biopsies.
Authors
Panagiotis J. Vlachostergios
Lutheran Medical Center, Brooklyn, NY
Panagiotis J. Vlachostergios , Nicolas Peruzzo , Jones Nauseef , Clara Oromendia , Jyothi Manohar , Ana M. Molina , David M. Nanus , Himisha Beltran , Scott T. Tagawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 278)
DOI
10.1200/JCO.2019.37.7_suppl.278
Abstract #
278
Poster Bd #
M13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Genomic, clinical characteristics, and treatment outcomes of patients with metastatic castration-sensitive prostate cancer with SPOP mutations: Analysis from the Kaiser Permanente Northern California Healthcare System.
First Author: Sachdev P. Thomas
Poster
2021 Genitourinary Cancers Symposium
SPOP mutations in prostate cancer: Clinical and genomic features.
First Author: Mari Nakazawa
Poster
2019 Genitourinary Cancers Symposium
Identification, incidence and clinical outcomes of patients (pts) with hypermutated prostate cancer (PC).
First Author: Simon Yuen Fai Fu
Poster
2019 Genitourinary Cancers Symposium
EphB4-EphrinB2 receptor-ligand pair as a novel target in prostate cancer (PC).
First Author: Sarmad Sadeghi